{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:08Z","timestamp":1792090448683,"version":"4.4.0"},"reference-count":405,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer is one of the major causes of mortality and is the second leading cause of death. Diabetes mellitus is a serious and growing problem worldwide, and its prevalence continues to grow; it is the 12th leading cause of death. An association between diabetes mellitus and cancer has been suggested for more than 100 years. Diabetes is a common disease diagnosed among patients with cancer, and evidence indicates that approximately 8\u201318% of patients with cancer have diabetes, with investigations suggesting an association between diabetes and some particular cancers, increasing the risk for developing cancers such as pancreatic, liver, colon, breast, stomach, and a few others. Breast and colorectal cancers have increased from 20% to 30% and there is a 97% increased risk of intrahepatic cholangiocarcinoma or endometrial cancer. On the other hand, a number of cancers and cancer therapies increase the risk of diabetes mellitus. Complications due to diabetes in patients with cancer may influence the choice of cancer therapy. Unfortunately, the mechanisms of the associations between diabetes mellitus and cancer are still unknown. The aim of this review is to summarize the association of diabetes mellitus with selected cancers and update the evidence on the underlying mechanisms of this association.<\/jats:p>","DOI":"10.3390\/ijms25137476","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T12:21:03Z","timestamp":1720441263000},"page":"7476","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Associations between Diabetes Mellitus and Selected Cancers"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-8497","authenticated-orcid":false,"given":"Monika","family":"Pliszka","sequence":"first","affiliation":[{"name":"Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Cha\u0142ubi\u0144skiego Str. 5, 02-004 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Szablewski","sequence":"additional","affiliation":[{"name":"Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Cha\u0142ubi\u0144skiego Str. 5, 02-004 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2020). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region. 2000\u20132019, WHO."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(14)60886-2","article-title":"The global implications of diabetes and cancer","volume":"383","author":"Shi","year":"2014","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Liu, J., Ren, Z.H., Qiang, H., Wu, J., Shen, M., Zhang, L., and Lyn, J. (2020). Trends in the incidence of diabetes mellitus: Results from the Global Burden of Disease Study 2017 and implication for diabetes mellitus prevention. BMC Publ. Health, 20.","DOI":"10.1186\/s12889-020-09502-x"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1530\/ERC-12-0105","article-title":"Diabetes and pancreatic cancer","volume":"19","author":"Cui","year":"2012","journal-title":"Endocrinol. Relat. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Michailidis, M., Moraitou, D., Tata, D.A., Kalinderi, K., Papamitsou, T., and Papaliagkas, V. (2022). Alzheimer\u2019s disease as type 3 diabetes: Common pathophysiological mechanisms between Alzheimer\u2019s disease and type 2 diabetes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052687"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","article-title":"Type 2 diabetes and cancer: An umbrella review of observational and Mendelian randomized studies","volume":"30","author":"Papadimitriou","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.37349\/emed.2020.00013","article-title":"Type 2 diabetes and cancer: Problems and suggestions for best patient management","volume":"1","author":"Milluzzo","year":"2020","journal-title":"Explor. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Khan, R.M.M., Chua, Z.J.Y., Tan, J.C., Yang, Y., Liao, Z., and Zhao, Y. (2019). From pre-diabetes to diabetes: Diagnosis, treatment and translational research. Medicina, 55.","DOI":"10.3390\/medicina55090546"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S2213-8587(14)70161-5","article-title":"Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985\u20132011: A modeling study","volume":"2","author":"Gregg","year":"2014","journal-title":"Lancet Diabet. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Joung, K.H., Jeong, J.-W., and Ku, B.J. (2015). The association between type 2 diabetes mellitus and women cancer: The epidemiological evidence and putative mechanisms. BioMed Res. Intern., 2015.","DOI":"10.1155\/2015\/920618"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rahman, I., Athar, M.T., and Islam, M. (2021). Type 2 diabetes, obesity, and cancer share some common and critical pathways. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.600824"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, diabetes, and increased cancer progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPA.0b013e318209e05d","article-title":"Diabetes and pancreatic cancer: Chicken or egg?","volume":"40","author":"Magruder","year":"2011","journal-title":"Pancreas"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2337\/diaspect.27.4.276","article-title":"The diabetes-cancer link","volume":"27","author":"Collins","year":"2014","journal-title":"Diabetes Spectr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1136\/bmj.g7607","article-title":"Type 2 diabetes and cancer: Umbrella review of meta-analysis of observational studies","volume":"350","author":"Tsilidis","year":"2015","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2169\/internalmedicine.54.3413","article-title":"The development of fulminant type 1 diabetes during chemotherapy for rectal cancer","volume":"54","author":"Adachi","year":"2015","journal-title":"Intern. Med."},{"key":"ref_19","first-page":"107","article-title":"Fulminant type 1 diabetes mellitus onset during postoperative chemotherapy for breast cancer","volume":"53","author":"Yanase","year":"2010","journal-title":"Tonyobyo"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-8227(00)00143-1","article-title":"A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy","volume":"49","author":"Uto","year":"2000","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nm.3042","article-title":"Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes","volume":"19","author":"Diana","year":"2013","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2362.2008.02067.x","article-title":"Novel insights into glucocorticoid-mediated diabetogenic effects: Towards expansion of therapeutic options?","volume":"39","author":"Ouwens","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.2337\/dc15-0889","article-title":"Anti-PD-1 and anti-PDL-1 monoclonal antibodies causing type 1 diabetes","volume":"38","author":"Mellati","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Shahid, R.K., Ahmed, S., Le, D., and Yadav, S. (2021). Diabetes and cancer: Risk, challenges, management and outcomes. Cancers, 13.","DOI":"10.3390\/cancers13225735"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/15680266113136660067","article-title":"Use of insulin and insulin analogs and the risk of cancer\u2014Systematic review and meta-analysis of observational studies","volume":"8","author":"Karlstad","year":"2013","journal-title":"Curr. Drug. Saf."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic and thyroid cancer with glucagon-like peptide-1 based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s00125-017-4370-8","article-title":"SGLT2 inhibitors and risk of cancer in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Tang","year":"2017","journal-title":"Diabetologia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00592-008-0083-2","article-title":"Sulphonylureas and cancer: A case-control study","volume":"46","author":"Monami","year":"2009","journal-title":"Acta Diabetol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bioorg.2018.02.009","article-title":"Thiazolidinediones as antidiabetic agents: A critical review","volume":"77","author":"Nanjan","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11844","DOI":"10.1038\/s41598-023-38431-z","article-title":"Diabetes medication and cancer risk associations: A systematic review and meta-analysis of evidence over the past 10 years","volume":"13","author":"Chen","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4239\/wjd.v11.i6.227","article-title":"Diabetes and cancer: Epidemiological and biological links","volume":"11","author":"Wang","year":"2020","journal-title":"World J. Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10552-010-9521-x","article-title":"Non-cancer mortality among long-term survivors of adult cancer in Korea. National cancer registry study","volume":"216","author":"Shin","year":"2010","journal-title":"Cancer Causes Control."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4158\/EP10357.RA","article-title":"Significantly increased risk of cancer in patients with diabetes mellitus: A systematic review and meta-analysis","volume":"17","author":"Noto","year":"2011","journal-title":"Endocr. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Arreskov, A.B., Olsen, M.\u212b., Pouplier, S.S., Siersma, V., Andersen, C.L., Friss, S., and de Fine Olivarius, N. (2019). The impact of cancer on diabetes outcome. BMC Endocr. Disord., 19.","DOI":"10.1186\/s12902-019-0377-0"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1038\/s41598-023-36472-y","article-title":"High burden of diabetes and prediabetes among cancer patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia","volume":"13","author":"Wolde","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_36","first-page":"583786","article-title":"Diabetes and risk of cancer","volume":"2013","author":"Habib","year":"2013","journal-title":"Int. Sch. Res. Nat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaoncol.2018.1684","article-title":"Incidence of diabetes after cancer development: A Korean national cohort study","volume":"4","author":"Hwangbo","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/jnci\/djg105","article-title":"Cancer incidence in patients with type 1 diabetes mellitus: A population-based cohort study in Sweden","volume":"95","author":"Zendehdel","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tseng, C.-H. (2021). The relationship between diabetes mellitus and gastric cancer and the potential benefits of metformin: An extensive review of the literature. Biomolecules, 11.","DOI":"10.3390\/biom11071022"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"109866","DOI":"10.1016\/j.diabres.2022.109866","article-title":"Relationship between diabetes and risk of gastric cancer: A systematic review and meta-analysis of cohort study","volume":"187","author":"Guo","year":"2022","journal-title":"Diab. Res. Clin. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/ERC-12-0242","article-title":"Diabetes increases the risk of breast cancer: A meta-analysis","volume":"19","author":"Hardefeldt","year":"2012","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2337\/dc14-1996","article-title":"Cancer risk among people with type 1 and type 2 diabetes: Disentangling true associations, detection bias and reverse causation","volume":"38","author":"Harding","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Menini, S., Iacobini, C., Vitale, M., Pesce, C., and Pugliese, G. (2021). Diabetes and pancreatic cancer\u2014A dangerous liaison relying on carbonyl stress. Cancers, 13.","DOI":"10.3390\/cancers13020313"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1464-5491.2010.03011.x","article-title":"Cancer risk among patients hospitalized for Type 1 diabetes mellitus: A population-based cohort study in Sweden","volume":"27","author":"Shu","year":"2010","journal-title":"Diabet. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0031-1297969","article-title":"Diabetes mellitus and incidence and mortality of gastric cancer: A meta-analysis","volume":"120","author":"Tian","year":"2012","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study","volume":"52","author":"Hemkens","year":"2009","journal-title":"Diabetologia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated immunity","volume":"15","author":"Kahaly","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_48","first-page":"68","article-title":"Helicobacter pylori infection in children with type 1 diabetes mellitus: A case-control study","volume":"16","author":"Bazmamoun","year":"2016","journal-title":"J. Res. Health Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-016-3884-9","article-title":"Cancer incidence in persons with type 1 diabetes: A five-country study of 9.000 cancers in type 1 diabetes individuals","volume":"59","author":"Carstensen","year":"2016","journal-title":"Diabetologia"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zhu, B., and Qu, S. (2022). The relationship between diabetes mellitus and cancers and its underlying mechanisms. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.800995"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jjco\/hyy047","article-title":"Type 1 diabetes mellitus and risk of cancer: A meta-analysis of observational studies","volume":"48","author":"Sona","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.bjc.6602611","article-title":"Cancer incidence and mortality in patients with insulin-treated diabetes: A UK cohort study","volume":"92","author":"Swerdlow","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and diabetes: The increased risk of cancer and cancer-related mortality","volume":"95","author":"Gallhager","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021). 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes\u20132021. Diabetes Care, 44, S15\u2013S33.","DOI":"10.2337\/dc21-S002"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.dld.2016.12.010","article-title":"Prevalence of diabetes associated with diseases of the exocrine pancreas: A population based study","volume":"49","author":"Pandharkar","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/dmrr.2260","article-title":"Prevalence of diabetes mellitus secondary to pancreatic diseases (Type 3c)","volume":"28","author":"Ewald","year":"2012","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000329188","article-title":"Pancreatogenic diabetes: Special considerations for management","volume":"11","author":"Cui","year":"2011","journal-title":"Pancreatology"},{"key":"ref_58","unstructured":"Kahn, C.R., Weir, G.C., King, G.L., Jacobson, A.M., Moses, A.C., and Smith, R.J. (2005). Secondary forms of diabetes. Joslin\u2019s Diabetes Mellitus, Lippincott, Williams and Wilkins. [14th ed.]."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM199305203282001","article-title":"Pancreatitis and the risk of pancreatic","volume":"328","author":"Lowenfels","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.annepidem.2009.11.010","article-title":"Past medical history and pancreatic cancer risk: A results from a multicenter case-control study","volume":"20","author":"Maisonneuve","year":"2010","journal-title":"Annals Epidemiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1440-1746.2011.06938.x","article-title":"Diabetes mellitus correlates with increased risk of pancreatic cancer: A population-based cohort study in Taiwan","volume":"27","author":"Liao","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_62","first-page":"1135","article-title":"Tropical or malnutrition-related diabetes: A real syndrome?","volume":"1","author":"Taylor","year":"1986","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.2337\/dc08-s244","article-title":"Is pancreatic (Type 3c) diabetes underdiagnosed and misdiagnosed?","volume":"31","author":"Hardt","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/gast.2000.19286","article-title":"Risk factors for diabetes mellitus in chronic pancreatitis","volume":"119","author":"Malka","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e001060","DOI":"10.1136\/bmjdrc-2019-001060","article-title":"\u03b2-cell function or insulin resistance was associated with the risk of type 2 diabetes among women with or without obesity and a history of gestational diabetes","volume":"8","author":"Fan","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1753-0407.12988","article-title":"Gestational diabetes mellitus and risk of incident primary cancer: A population-based retrospective cohort study","volume":"12","author":"Pace","year":"2020","journal-title":"J. Diabetes"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e024583","DOI":"10.1136\/bmjopen-2018-024583","article-title":"Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: A nationwide cohort study in Taiwan","volume":"9","author":"Peng","year":"2019","journal-title":"BMJ Open"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Han, K.T., Cho, G.J., and Kim, E.H. (2018). Evaluation of the association between gestational diabetes mellitus at the first pregnancy and cancer within 10 years postpartum using National Health Insurance data in South Korea. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15122646"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/dme.12796","article-title":"Short-term risk of cancer among women with previous gestational diabetes: A population-based study","volume":"33","author":"Bejaimal","year":"2016","journal-title":"Diabet. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Dong, W.-W., Zhang, D.-L., Wang, Z.-H., Lv, C.-Z., Zhang, P., and Zhang, H. (2022). Different types of diabetes mellitus and risk of thyroid cancer: A meta-analysis of cohort studies. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.971213"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/aje\/kwm322","article-title":"Population-based canse-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states","volume":"167","author":"Rollison","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10552-011-9825-5","article-title":"Gestational diabetes and risk of incidence primary cancer: A large historical cohort study in Israel","volume":"22","author":"Sella","year":"2011","journal-title":"Cancer Causes Control"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00001648-199811000-00014","article-title":"Pregnancy characteristic and maternal risk of breast cancer","volume":"9","author":"Troisi","year":"1998","journal-title":"Epidemiology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/B:CACO.0000024225.14618.a8","article-title":"Hyperinsulinemia and increased risk of breast cancer: Findings from the British Women\u2019s Heart and Healthy Study","volume":"15","author":"Lawlor","year":"2004","journal-title":"Cancer Causes Control"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-007-9585-9","article-title":"Gestational diabetes and the risk of breast cancer among women in Jerusalem perinatal study","volume":"108","author":"Perrin","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.25362","article-title":"Risk of cancer in a large cohort of U.S. Veterans with diabetes","volume":"128","author":"Atchison","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/07435800.2014.934961","article-title":"Diabetes mellitus and the risk of prostate cancer: An update and cumulative meta-analysis","volume":"40","author":"Mo","year":"2015","journal-title":"Endocr. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of case-specific death","volume":"364","author":"Kaptoge","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1001\/jama.2008.824","article-title":"Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis","volume":"300","author":"Barone","year":"2008","journal-title":"JAMA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/dc12-0002","article-title":"Diabetes and cause-specific mortality in a prospective cohort study of one million U.S. adults","volume":"35","author":"Campbell","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00125-017-4229-z","article-title":"Association between type 2 diabetes and risk of cancer mortality: A pooled analysis of over 771,000 individuals in the Asia cohort consortium","volume":"60","author":"Chen","year":"2017","journal-title":"Diabetologia"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"FSO248","DOI":"10.4155\/fsoa-2017-0081","article-title":"Patient outcomes from lung cancer and diabetes mellitus: A matched case-control study","volume":"4","author":"Karlin","year":"2018","journal-title":"Future Sci. OA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/cd19-0077","article-title":"Review of associations between type 2 diabetes and cancer","volume":"38","author":"Bonagiri","year":"2020","journal-title":"Clin. Diabet. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/oncolo\/oyad080","article-title":"Management of patients with pancreatic cancer using the \u201cRight Track\u201d Model","volume":"28","author":"Rosenzweig","year":"2023","journal-title":"Oncologist"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.2147\/CMAR.S211972","article-title":"The relationship between pancreatic cancer and type 2 diabetes: Cause and consequence","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/carcin\/bgw022","article-title":"Pancreatic cancer: Associations of inflammatory, potential of diet, cigarette smoking and long-standing diabetes","volume":"37","author":"Antwi","year":"2016","journal-title":"Carcinogenesis"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1038\/ctg.2015.44","article-title":"Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus","volume":"6","author":"Munigala","year":"2015","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Song, S., Wang, B., Zhang, X., Hao, L., Li, Z., and Sun, S. (2015). Long-term diabetes mellitus is associated with an increased risk of pancreatic cancer: A meta-analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134321"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic cancer following diabetes: A population-based study","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10552-010-9686-3","article-title":"Diabetes and risk of pancreatic cancer: A pooled analysis of three large case-control studies","volume":"22","author":"Li","year":"2011","journal-title":"Cancer Cause Control"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mdu276","article-title":"Diabetes, antidiabetic medications, and pancreatic cancer risk: An analysis from the International Pancreatic Cancer Case-Control Consortium","volume":"25","author":"Bosetti","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1245\/s10434-014-3625-6","article-title":"Association of diabetes mellitus and pancreatic adenocarcinoma: A meta-analysis of 88 studies","volume":"21","author":"Batabyal","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jnci\/djy090","article-title":"Pancreatic cancer following incident diabetes in African Americans and Latinos. The multiethnic cohort","volume":"111","author":"Setiawan","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.cgh.2006.06.024","article-title":"New-onset diabetes and pancreatic cancer","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_98","first-page":"331","article-title":"Diabetes and pancreatic cancer","volume":"58","author":"Muniraj","year":"2012","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mc.20771","article-title":"Diabetes and pancreatic cancer","volume":"51","author":"Li","year":"2012","journal-title":"Mol. Carcinog."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.6004\/jnccn.2020.7653","article-title":"Understanding the prevalence of prediabetes and diabetes in patients with cancer in clinical practice: A real-world cohort study","volume":"19","author":"Ose","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"100155","DOI":"10.1016\/j.esmoop.2021.100155","article-title":"Early prediction of pancreatic cancer from new-onset diabetes: An Associazione Italiana Oncologica Medica (AIOM)\/Associazione Medici Diabetologi (AMD)\/Societa Italiana Endocrinologia (SIE)\/Societa Italiana Farmacologia (SIF) multidisciplinary consensus position paper","volume":"6","author":"Gallo","year":"2021","journal-title":"ESMO Open Cancer Horiz."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","article-title":"Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus","volume":"134","author":"Pannala","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/MCG.0b013e318238348c","article-title":"New-onset diabetes patients need pancreatic cancer screening?","volume":"46","author":"Lee","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma. A review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2014.08.007","article-title":"Hepatocellular carcinoma epidemiology","volume":"28","author":"Bosetti","year":"2014","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11892-017-0851-x","article-title":"Type 2 diabetes and hepatocellular carcinoma: Risk factors and pathogenesis","volume":"17","author":"Wainwright","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hep.21208","article-title":"Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence are hepatitis virus infection","volume":"43","author":"Lai","year":"2006","journal-title":"Hepatology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"270","DOI":"10.21037\/atm.2017.04.41","article-title":"Type 2 diabetes mellitus and risk of hepatocellular carcinoma: Spotlight on nonalcoholic fatty liver disease","volume":"5","author":"Mantovani","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Gurney, J., Stanley, J., Teng, A., Krebs, J., Koea, J., Lao, C., Lawrenson, R., Meredith, I., Sika-Paotonu, D., and Sarfati, D. (2022). Cancer and diabetes co-occurrence: A national study with 44 million person-years of follow-up. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0276913"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"100025","DOI":"10.1016\/j.deman.2021.100025","article-title":"Impact of diabetes on the increased risk of hepatic cancer: An updated review of biological aspects","volume":"4","author":"Gadad","year":"2021","journal-title":"Diabet. Epidemiol. Manag."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Therap."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common under lying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marzero","year":"2002","journal-title":"Hepatology"},{"key":"ref_115","first-page":"52","article-title":"Nonalcoholic fatty liver disease","volume":"70","author":"Angulo","year":"2005","journal-title":"Rev. Gastroenterol. Mex."},{"key":"ref_116","first-page":"15","article-title":"Prevalence of obesity, diabetes mellitus and hyperlipidemia in patients with cryptogenic liver cirrhosis","volume":"25","author":"Duseja","year":"2004","journal-title":"Trop. Gastroenterol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3748\/wjg.v16.i12.1436","article-title":"Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: Our case series and literature reviews","volume":"16","author":"Takuma","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progress to hepatocellular carcinoma in the absence cirrhosis","volume":"10","author":"Ertle","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CEJ.0b013e3283481d89","article-title":"Diabetes mellitus and increased risk of cholangiocarcinoma: A meta-analysis","volume":"21","author":"Jing","year":"2012","journal-title":"Europ. J. Canc. Prev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nm1785","article-title":"Hepatic insulin resistance directly promotes formation of cholesterol gallstones","volume":"14","author":"Biddinger","year":"2008","journal-title":"Nat. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14740\/wjon1254","article-title":"Esophageal cancer: An update surveillance epidemiology and end results database analysis","volume":"11","author":"Lopez","year":"2020","journal-title":"World J. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10552-011-9874-9","article-title":"Risk of esophageal cancer in diabetes mellitus: A meta-analysis of observational study","volume":"23","author":"Huang","year":"2012","journal-title":"Cancer Causes Control"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4093\/dmj.2019.0177","article-title":"Diabetes and cancer: Cancer should be screened in routine diabetes assessment","volume":"43","author":"Suh","year":"2019","journal-title":"Diabet. Metab. J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/cas.12597","article-title":"Population-based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women","volume":"106","author":"Xu","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/jgh.13329","article-title":"Diabetic biomarkers and the risk of proximal or distal gastric cancer","volume":"31","author":"Kim","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10552-010-9515-8","article-title":"Diabetes and risk of incident cancer: A large population-based cohort study in Israel","volume":"21","author":"Chodick","year":"2010","journal-title":"Cancer Causes Control"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10552-012-9996-8","article-title":"Diabetes mellitus as a risk factor for gastrointestinal cancer among postmenopausal women","volume":"24","author":"Luo","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41416-019-0470-1","article-title":"Prediabetes and diabetes in relation to risk of gastric adenocarcinoma","volume":"120","author":"Zheng","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/01635581.2012.676141","article-title":"Diabetes mellitus and cancer risk in network of case-control studies","volume":"64","author":"Bosetti","year":"2012","journal-title":"Nutr. Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/dme.12435","article-title":"The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes\u2014The 2001-2006 ENTRED cohort","volume":"31","author":"Romon","year":"2014","journal-title":"Diabet. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canep.2018.04.008","article-title":"Gastrointestinal cancer incidence in type 2 diabetes mellitus: Results from a large population-based cohort study in the U.K","volume":"54","author":"Peeters","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1753-0407.12108","article-title":"Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: A longitudinal (REACTION) study","volume":"6","author":"Bi","year":"2014","journal-title":"J. Diabet."},{"key":"ref_134","first-page":"342","article-title":"Incidence of cancer among diabetic and non-diabetic adult Israeli Arabs","volume":"15","author":"Idilbi","year":"2013","journal-title":"Isr. Med. Assoc."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1038\/s41598-017-09498-2","article-title":"Dietary glycemic index, glycemic load, and cancer risk: Results from the EPIC-Italy study","volume":"7","author":"Sieri","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.21873\/anticanres.15666","article-title":"Diabetes mellitus and oral cancer: A retrospective study from Austria","volume":"42","author":"Remschmidt","year":"2022","journal-title":"Anticancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diabres.2010.04.016","article-title":"Oral mucosal lesions in non-oral habit diabetic patients and association of diabetes mellitus with oral precancerous lesions","volume":"89","author":"Saini","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/odi.13289","article-title":"Diabetes mellitus and oral cancer\/oral potentially malignant disorder: A systematic review and meta-analysis","volume":"27","year":"2021","journal-title":"Oral Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14341\/probl12741","article-title":"Diabetes mellitus and cancer: A system of insulin-like growth factors","volume":"67","author":"Frantsiyants","year":"2021","journal-title":"Probl. Ecdocrinol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","article-title":"Colorectal cancer","volume":"375","author":"Cunningham","year":"2010","journal-title":"Lancet"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","article-title":"Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: Different pathways to failure","volume":"16","author":"Elzirik","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_142","first-page":"9","article-title":"Diabetes association of polyps and colon cancer","volume":"91","author":"Myrcha","year":"2019","journal-title":"Pol. Przegl. Chir."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ijc.31311","article-title":"Type 2 diabetes and colorectal cancer survival. The multiethnic cohort","volume":"143","author":"Amshoff","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jdiacomp.2011.11.003","article-title":"Diabetes and the risk for colorectal cancer","volume":"26","author":"Erbach","year":"2012","journal-title":"J. Diabetes Complicat."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1053\/j.gastro.2010.06.072","article-title":"Perspective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men","volume":"139","author":"Campbell","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/diacare.28.7.1805","article-title":"Diabetes and colorectal cancer incidence in the cohort of Swedish men","volume":"28","author":"Larsson","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e2343333","DOI":"10.1001\/jamanetworkopen.2023.43333","article-title":"Type 2 diabetes and colorectal cancer risk","volume":"6","author":"Lawler","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/dc14-1175","article-title":"The risk of colorectal cancer in patients with type 2 diabetes: Associations with treatment stage and obesity","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"46527","DOI":"10.1038\/srep46527","article-title":"Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation","volume":"7","author":"Masclee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/DCR.0b013e3182a479f9","article-title":"Diabetes mellitus and colorectal cancer prognosis: A meta-analysis","volume":"56","author":"Mills","year":"2013","journal-title":"Dis. Colon Rectum."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Zhu, B., Wu, X., Wu, B., Pei, D., Zhang, L., and Wei, L. (2017). The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176068"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1136\/gut.2011.237727","article-title":"Type 2 diabetes risk variants and colorectal cancer risk: The Multiethnic Cohort and PAGE studies","volume":"60","author":"Cheng","year":"2011","journal-title":"Gut"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Ali Khan, U., Fallah, M., Sundquist, K., Sundquist, J., Brenner, H., and Kharazmi, E. (2020). Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003431"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s10620-012-2055-1","article-title":"Diabetes mellitus and the incidence of colorectal cancer: An update systematic review and meta-analysis","volume":"57","author":"Deng","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.gastro.2005.05.051","article-title":"Insulin-like growth factor-1 and insulin are associated with the presence and advancement of adenomatous polyps","volume":"129","author":"Schoen","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12029-011-9316-7","article-title":"Association of type 2 diabetes and colon cancer adenomas","volume":"43","author":"Eddi","year":"2012","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s10620-007-9970-6","article-title":"The association of elevated HbA1c on the behavior of adenomatous polyps in patients with type-II diabetes mellitus","volume":"53","author":"Sidiqui","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ijc.32310","article-title":"Diabetes and cancer risk. A Mendelian randomized study","volume":"146","author":"Goto","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00125-011-2051-6","article-title":"Diabetes mellitus and incidence of kidney cancer: A meta-analysis of cohort studies","volume":"54","author":"Larsson","year":"2011","journal-title":"Diabetologia"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Russo, P. (2012). End stage and chronic kidney disease associations with renal cancer. Front. Oncol., 2.","DOI":"10.3389\/fonc.2012.00028"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.maturitas.2011.11.009","article-title":"Chronic kidney disease and diabetes","volume":"71","author":"Pyram","year":"2012","journal-title":"Maturitas"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.pas.0000194296.74097.87","article-title":"Evaluation of the nonneoplastic pathology in tumor nephroctomy specimens: Predicting the risk of progressive renal failure","volume":"30","author":"Bijol","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAP.0b013e3181e3c02d","article-title":"The non-neoplastic kidney in tumor nephrectomy specimens: What can it show and what is important?","volume":"174","author":"Bonsib","year":"2010","journal-title":"Adv. Ant. Pathol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7150\/jca.3718","article-title":"Diabetes and risk of renal cell carcinoma","volume":"3","author":"Habib","year":"2012","journal-title":"J. Cancer"},{"key":"ref_165","first-page":"769","article-title":"Impact of diabetes mellitus in patients with non-muscle invasive bladder carcinoma: A retrospective cohort study","volume":"11","author":"Hwang","year":"2011","journal-title":"J. Urol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-9378-7-19","article-title":"Role of chronic E. coli infection in the process of bladder cancer\u2014An experimental study","volume":"7","author":"Salmon","year":"2012","journal-title":"Inf. Agents Cancer"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Xu, X., Wu, J., Mao, Y., Zhu, Y., Hu, Z., Xu, X., Lin, Y., Chen, H., Zheng, X., and Qin, J. (2013). Diabetes mellitus and risk of bladder cancer: A meta-analysis of cohort studies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058079"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Zhu, Z., Wang, X., Shen, Z., Lu, Y., Zhong, S., and Xu, C. (2013). Risk of bladder cancer in patients with diabetes mellitus: An updated meta-analysis of 36 observational studies. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-310"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Zhu, Z., Zhang, X., Shen, Z., Zhong, S., Wang, X., Lu, Y., and Xu, C. (2013). Diabetes mellitus and risk of bladder cancer: A meta-analysis of cohort studies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056662"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/bjc.2015.178","article-title":"Diabetes mellitus and the risk of bladder cancer: An Italian case-cancer study","volume":"113","author":"Turati","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10552-012-0143-3","article-title":"Diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women\u2019s Health Study","volume":"24","author":"Prizment","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e8588","DOI":"10.1097\/MD.0000000000008588","article-title":"Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort-studies","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e007470","DOI":"10.1136\/bmjopen-2014-007470","article-title":"Risk of bladder cancer in patients with diabetes: A retrospective cohort study","volume":"5","author":"Goossens","year":"2015","journal-title":"BMJ Open"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: A population-based study","volume":"9","author":"Bray","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","article-title":"Thyroid cancer: Incidence and mortality trends in China, 2005-2015","volume":"68","author":"Wang","year":"2020","journal-title":"Endocrine"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jncc.2020.12.001","article-title":"Cancer incidence and mortality in China, 2015","volume":"1","author":"Zhang","year":"2021","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3346\/jkms.2010.25.8.1113","article-title":"Cancer Statistics in Korea: Incidence, Mortality and Survival","volume":"25","author":"Jung","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1089\/thy.2019.0684","article-title":"Long-term declines of thyroid cancer mortality: An international Age-Period-Cohort analysis","volume":"30","author":"Li","year":"2020","journal-title":"Thyroid"},{"key":"ref_180","first-page":"1","article-title":"A population-based case-control study of thyroid cancer","volume":"79","author":"Ron","year":"1987","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_181","first-page":"25","article-title":"Radiation Carcinogenesis","volume":"3","author":"Hirohata","year":"1976","journal-title":"Semin. Oncol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Yeo, Y., Ma, S.-H., Hwang, Y., Horn-Ross, P.L., Hsing, A., Lee, K.-E., Park, Y.J., Park, D.-J., Yoo, K.-Y., and Park, S.K. (2014). Diabetes mellitus and risk of thyroid cancer: A meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098135"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2147\/DMSO.S450321","article-title":"Diabetes mellitus and thyroid cancers: Risky correlation, underlying mechanisms and clinical prevention","volume":"17","author":"Wu","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1182\/blood-2011-06-362830","article-title":"Increased incidence of non-Hodgkin lymphoma, leukemia, and diabetes mellitus type 2: A meta-analysis of observational studies","volume":"119","author":"Castillo","year":"2012","journal-title":"Blood"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3324\/haematol.12297","article-title":"Diabetes and the risk of non-Hodgkin\u2019s lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition","volume":"93","author":"Khan","year":"2008","journal-title":"Haematologica"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.21037\/tcr.2018.10.14","article-title":"HRCT features distinguishing minimally invasive adenocarcinoma from invasive adenocarcinomas appearing as mixed ground-glass nodules","volume":"7","author":"Yu","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.21037\/tlcr.2019.11.01","article-title":"Type 2 diabetes mellitus does not increase the risk of lung cancer among never-smokers: A nationwide cohort study","volume":"8","author":"Park","year":"2019","journal-title":"Transl. Lung Cancer"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1467-789X.2007.00396.x","article-title":"Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer","volume":"8","author":"Rose","year":"2007","journal-title":"Obes. Rev."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/bjc.2012.414","article-title":"Diabetes and breast cancer risk: A meta-analysis","volume":"107","author":"Boyle","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2840-8-33","article-title":"Combined effect of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women","volume":"8","author":"Alokail","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/carcin\/bgm081","article-title":"Diabetes and risk of breast cancer in Asian-American women","volume":"28","author":"Wu","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref_192","first-page":"1061","article-title":"Association between diabetes mellitus and breast cancer risk: A meta-analysis of the literature","volume":"12","author":"Liao","year":"2011","journal-title":"Asian Pac. J. Cancer Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10549-015-3323-5","article-title":"The association between diabetes and breast cancer stage at diagnosis: A population based study","volume":"150","author":"Lipscombe","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41416-023-02345-4","article-title":"Diabetes mellitus and risk of breast cancer: A large-scale, prospective, population-based study","volume":"129","author":"Xiong","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.annonc.2020.12.008","article-title":"A prospective study of type 2 diabetes, metformin use, and risk of breast cancer","volume":"32","author":"Park","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO clinical practical guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pathol.2.010506.091905","article-title":"Endometrial carcinoma","volume":"2","author":"Ellenson","year":"2007","journal-title":"Annu. Rev. Pathol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","article-title":"Diabetes mellitus and risk of endometrial cancer: A meta-analysis","volume":"50","author":"Friberg","year":"2007","journal-title":"Diabetologia"},{"key":"ref_199","first-page":"S94","article-title":"Weight control and physical activity in cancer prevention: International evaluation of the evidence","volume":"11","author":"Vainio","year":"2002","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/jnci\/djh291","article-title":"Anthropometry, physical activity, and endometrial cancer risk: Results from the Netherlands Cohort Study","volume":"96","author":"Schouten","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/aje\/kwm333","article-title":"Diabetes and endometrial cancer: An evolution of the modifying effects of other risk factors","volume":"167","author":"Saltzman","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Chen, H.-F., Liu, M.D., Chen, P., Chen, L.-H., Chang, Y.-H., Wen, P.C., and Li, C.-Y. (2013). Risks of breast and endometrial cancer in women with diabetes: A population based cohort study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067420"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/IGC.0b013e31827b8430","article-title":"The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: A meta-analysis of prospective cohort studies","volume":"23","author":"Zhang","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_204","first-page":"131","article-title":"Body mass index, diabetes and survival after diagnosis of endometrial cancer: A report from the HUNT-Survey","volume":"37","author":"Lindermann","year":"2014","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ygyno.2004.06.027","article-title":"Diabetes as a risk factor for death following endometrial cancer","volume":"94","author":"Folsom","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/dc11-1313","article-title":"Mortality after incident cancer in people with and without type 2 diabetes: Impact of metformin on survival","volume":"35","author":"Currie","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2014.07.095","article-title":"Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies","volume":"135","author":"Liao","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.21873\/anticanres.11240","article-title":"Implementing the risk of ovarian malignancy algorithm adding obesity as a predictive factor","volume":"36","author":"Anastasi","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1515\/cclm-2017-0982","article-title":"Linking type 2 diabetes and gynecological cancer: An introductory overview","volume":"56","author":"Anastasi","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: A hypothesis","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/1055-9965.EPI-12-0867","article-title":"Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort","volume":"21","author":"Gapstur","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/IGC.0b013e31828189b2","article-title":"Diabetes mellitus and ovarian cancer risk: A systematic review and meta-analysis of observational studies","volume":"23","author":"Lee","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2014.09.004","article-title":"Diabetes mellitus and ovarian cancer: More complex than just increasing risk","volume":"135","author":"Shah","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1634\/theoncologist.2015-0111","article-title":"The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia","volume":"20","author":"Kuo","year":"2015","journal-title":"Oncologist"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.3802\/jgo.2016.27.e28","article-title":"Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer","volume":"27","author":"Jlamset","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2010209","DOI":"10.3121\/cmr.2013.1160","article-title":"Prostate cancer risk in pre-diabetic men: A matched cohort study","volume":"11","author":"Onitilo","year":"2013","journal-title":"Clin. Med. Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/pcan.2012.40","article-title":"Type 2 diabetes and risk of prostate cancer: A meta-analysis of observational studies","volume":"16","author":"Bansal","year":"2013","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1186\/s40064-016-3233-y","article-title":"Diabetes and mortality in patients with prostate cancer: A meta-analysis","volume":"5","author":"Lee","year":"2016","journal-title":"Springerplus"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/ijc.31587","article-title":"Heterogenity in risk of prostate cancer. A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus","volume":"143","author":"Garmo","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/curroncol31020075","article-title":"Insulin resistance: The increased risk of cancers","volume":"31","author":"Szablewski","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Szablewski, L. (2024). Changes in cells associated with insulin resistance. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042397"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-020-0329-9","article-title":"Insulin-PI3K signaling: An evolutionarily insulated metabolic driver of cancer","volume":"16","author":"Hopkins","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.onc.1204064","article-title":"Insulin and IGF-1 stimulate the \u03b2-catenin pathway through two signalling cascade involving GSK-3\u03b2 inhibition and Ras activation","volume":"20","author":"Cadoret","year":"2001","journal-title":"Oncogene"},{"key":"ref_227","first-page":"3145","article-title":"Beta-catenin regulates vascular endothelial growth factor expression in colon cancer","volume":"63","author":"Easwaran","year":"2003","journal-title":"Cancer Res."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1159\/000527123","article-title":"The history of the insulin-like growth factor system","volume":"95","author":"Miller","year":"2021","journal-title":"Horm. Res. Pediatr."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2174\/138161208784139765","article-title":"AGE-RAGE system and carcinogenesis","volume":"14","author":"Abe","year":"2008","journal-title":"Cur. Pharm. Des."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/ijc.30599","article-title":"Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies","volume":"140","author":"Pang","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer. A consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1172\/JCI129187","article-title":"Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome","volume":"129","author":"Kahn","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1210\/jc.2015-2892","article-title":"Predictors of whole-body insulin sensitivity across ages and adiposity in adult humans","volume":"101","author":"Lalia","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of US adults","volume":"341","author":"Calle","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/oby.2008.610","article-title":"Cancer incidence and mortality after gastric bypass surgery","volume":"17","author":"Adams","year":"2009","journal-title":"Obesity"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.soard.2008.08.025","article-title":"Bariatric surgery reduces cancer risk in morbidity obese patients","volume":"4","author":"Christou","year":"2008","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/ERC-14-0580","article-title":"Body fatness as a cause of cancer: Epidemiologic clues to biologic mechanisms","volume":"22","author":"Byers","year":"2015","journal-title":"Endocrinol. Relat. Cancer"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-009-1556-8","article-title":"Pancreatic duct replication is increased with obesity and type 2 diabetes in humans","volume":"53","author":"Butler","year":"2010","journal-title":"Diabetologia"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","article-title":"Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk","volume":"23","author":"Stern","year":"2016","journal-title":"Cell Metab."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-016-0163-7","article-title":"Adipocyte lipolysis links obesity to breast cancer growth: Adipocyte-derived fatty acids drive breast cancer cell proliferation and migration","volume":"5","author":"Balaban","year":"2017","journal-title":"Cancer Metab."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prca.201100052","article-title":"Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders","volume":"6","author":"Lehr","year":"2012","journal-title":"Proteomics Clin. Appl."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mc.22485","article-title":"Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins","volume":"56","author":"Bosquet","year":"2017","journal-title":"Mol. Carcinog."},{"key":"ref_246","first-page":"1607","article-title":"High-fat diet-induced adipokine and cytokine alterations promote the progression of cancer in vivo and in vitro","volume":"15","author":"Hu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_247","first-page":"298","article-title":"Leptin stimulates the epithelial-mesenchymal transition and pro-angiogenic capability of cholangiocarcinoma cells through the miR-122\/PKM2 axis","volume":"55","author":"Peng","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_248","first-page":"135438","article-title":"MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer","volume":"6","author":"Wang","year":"2021","journal-title":"JCI Insight"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Parida, S., Siddharth, S., and Sharma, D. (2019). Adiponectin, obesity and cancer: Clash of the bigwigs in health and disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102519"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","article-title":"ACR30\/adiponectin: An adipokine regulating glucose and lipid metabolism","volume":"13","author":"Berg","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_251","first-page":"5699","article-title":"Association of serum adiponectin levels with breast cancer risk","volume":"9","author":"Miyoshi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cytogfr.2017.11.002","article-title":"The potential role of leptin in tumor invasion and metastasis","volume":"38","author":"Ray","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/jca.17648","article-title":"Role of tumor microenvironment in tumorigenesis","volume":"8","author":"Wang","year":"2017","journal-title":"J. Cancer"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"17151","DOI":"10.1038\/s41598-019-50268-z","article-title":"Compressive remodeling alters fluid transport properties of collagen networks\u2014Implications for tumor growth","volume":"9","author":"Ferruzzi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Jiang, Z., Hsu, J.L., Li, Y., Hortobagyi, G.N., and Huang, M.C. (2020). Cancer cell metabolism bolsters immunotherapy resistance by promoting an immunosuppressive tumor microenvironment. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01197"},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Gong, C., Yu, X., Zhang, W., Han, L., Wang, R., Wang, Y., Gao, S., and Yuan, Y. (2021). Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles. J. Nanobiotechnol., 19.","DOI":"10.1186\/s12951-021-00805-8"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cphy.c170008","article-title":"Contribution of adipose tissue to development of cancer","volume":"8","author":"Cozzo","year":"2017","journal-title":"Comp. Physiol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Sotgia, F., Martinez-Outschoorn, U.E., and Lisanti, M.P. (2011). Mitochondrial oxidative stress drives tumor progression and metastatic: Should we use antioxidants as a key component of cancer treatment and prevention. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-62"},{"key":"ref_262","unstructured":"Garcia, M., Jemal, A., Ward, E.M., Center, M.M., Hao, Y., Siegel, R.L., and Thun, M.J. (2007). Global Cancer Facts & Figures 2007, American Cancer Society."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/dme.12063","article-title":"Insulin resistance: A risk marker for disease and disability in the older person","volume":"30","author":"Krentz","year":"2013","journal-title":"Diabetes Med."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.1104343","article-title":"Mitochondrial dysfunction and type 2 diabetes","volume":"307","author":"Lowell","year":"2005","journal-title":"Science"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.1082889","article-title":"Mitochondrial dysfunction in the elderly: Possible role in insulin resistance","volume":"300","author":"Petersen","year":"2003","journal-title":"Science"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: Back to Virchov?","volume":"357","author":"Balkwil","year":"2001","journal-title":"Lancet"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","article-title":"Cytokine-mediated link between innate immunity, inflammation and cancer","volume":"117","author":"Lin","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: A leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2014.0026","article-title":"The role of cytokines in breast cancer development and progression","volume":"35","author":"Castro","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.48.1.1","article-title":"Role of oxidative stress in diabetic complications: A new perspective on an old paradigm","volume":"48","author":"Baynes","year":"1999","journal-title":"Diabetes"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-10-0851","article-title":"Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes","volume":"164","author":"Engelen","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1073\/pnas.90.14.6434","article-title":"Lipid advanced glycosylation: Pathway for lipid oxidation in vivo","volume":"90","author":"Bucala","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1196\/annals.1333.051","article-title":"Advanced glycation in health and disease. Role of the modern environment","volume":"1043","author":"Vlassara","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2017.07.001","article-title":"AGEs, RAGEs and s-RAGE; friend or foe for cancer","volume":"49","author":"Ahmad","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12079-012-0181-3","article-title":"A multicellular signal transduction network of AGE\/RAGE signaling","volume":"7","author":"Soman","year":"2013","journal-title":"J. Cell Commun. Signal."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/med.20073","article-title":"Intervention strategies to inhibit protein carbonylation by lipoxydation-derived reactive carbonyls","volume":"27","author":"Aldini","year":"2007","journal-title":"Med. Res. Rev."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11033-020-06084-0","article-title":"A review on mechanism of inhibition of advancer glycation end products formation by plant derived polyphenolic compounds","volume":"48","author":"Anwar","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_278","first-page":"16669","article-title":"Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: Prospective cohort study","volume":"368","author":"Li","year":"2020","journal-title":"BMJ"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0953-6205(00)00106-0","article-title":"Diabetes mellitus and cancer","volume":"11","author":"Czyzyk","year":"2000","journal-title":"Europ. J. Intern. Med."},{"key":"ref_280","first-page":"342","article-title":"PI3K\/Akt\/mTOR inhibitors in breast cancer","volume":"12","author":"Lee","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer","volume":"380","author":"Ciruelos","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/annonc\/mdn066","article-title":"Temisirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognosis","volume":"19","author":"Bellmunt","year":"2008","journal-title":"Annu. Oncol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.molmet.2014.06.004","article-title":"Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo","volume":"3","author":"Kleinert","year":"2014","journal-title":"Mol. Metab."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2174\/156800909789271495","article-title":"Crosstalk between epidermal growth factor receptor and insulin-like growth factor-1 receptor signaling. Implications for cancer therapy","volume":"9","author":"Oliveira","year":"2009","journal-title":"Cancer Drug Targets"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia. An update","volume":"12","author":"Pollack","year":"2012","journal-title":"Nat. Rep. Cancer"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1158\/1078-0432.CCR-07-1118","article-title":"Phase I dose escalation study of the anti- insulin-like growth factor I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors","volume":"13","author":"Haluska","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1200\/JCO.2007.15.9319","article-title":"Phase I, pharmacokinetics and pharmacodynamics study of the anti-insulin-like growth factor type 1 receptor monoclonal antibody CP-751,871 in patients with multiple myeloma","volume":"26","author":"Lacy","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/db06-0299","article-title":"Growth hormone regulates of p85\u03b1 expression and phosphoinositide 3-kinase activity in adipose tissue: Mechanism for growth hormone-mediated insulin resistance","volume":"56","author":"Iida","year":"2007","journal-title":"Diabetes"},{"key":"ref_289","first-page":"361","article-title":"Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer","volume":"12","author":"Scartuzzi","year":"2010","journal-title":"Curr. Opin. Mol. Ther."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"djv258","DOI":"10.1093\/jnci\/djv258","article-title":"A randomized phase II\/III study of Dalotuzumab in combination with cetuximab and irinotecan in chemorefractory, KRASWild-Type metastatic colorectal cancer","volume":"107","author":"Sclafani","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1470-2045(15)70081-1","article-title":"Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: A double-blind, randomized, phase 3 study","volume":"16","author":"Fassnacht","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10637-014-0164-8","article-title":"A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma","volume":"33","author":"Goyal","year":"2015","journal-title":"Investig. New Drugs"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.19.00816","article-title":"Randomized phase III study of ganetespib, a heat shock protein 90 inhibitor with docetaxel versus docetaxel in advanced non-small-cell lung cancer (GALAXY-2)","volume":"38","author":"Pillai","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1311107","article-title":"Certinib in ALK-Rearranged non-small-cell lung cancer","volume":"370","author":"Shaw","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.critrevonc.2006.12.008","article-title":"EGFR targeting therapies monoclonal antibodies versus tyrosine kinase inhibitors: Similarities and differences","volume":"62","author":"Dassonville","year":"2007","journal-title":"Crit. Rev. Oncol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10555-017-9687-8","article-title":"EGFR-targeted therapies in the post-genomic era","volume":"36","author":"Xu","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa1413654","article-title":"Rociletinib in EGFR-mutated non-small-cell lung cancer","volume":"372","author":"Sequist","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"17601","DOI":"10.1038\/s41598-019-54033-0","article-title":"Adverse effects of dasatinib on glucose-lipid metabolism in patients with chronic leukemia in the chronic phase","volume":"9","author":"Yu","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_300","first-page":"e124","article-title":"Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia","volume":"98","author":"Racil","year":"2013","journal-title":"Hematology"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1038\/cddis.2012.89","article-title":"Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and C-Jun in leukemia cells","volume":"3","author":"Heidari","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_302","first-page":"19","article-title":"Chemotherapy-induced nausea and vomiting","volume":"4","author":"Maustin","year":"2008","journal-title":"US Oncol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpainsymman.2012.06.019","article-title":"Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review","volume":"46","author":"Paulsen","year":"2013","journal-title":"J. Pain Symptom Manag."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"493","DOI":"10.6004\/jnccn.2012.0049","article-title":"Corticosteroids in the treatment of chemotherapy-induced nausea and vomiting","volume":"10","author":"Barbour","year":"2012","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_305","first-page":"CD010756","article-title":"Corticosteroids for the management of cancer related-related pain in adults","volume":"2021","author":"Haywood","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2016.67.4044","article-title":"Type 2 diabetes mellitus and cancer: The role of pharmacotherapy","volume":"34","author":"Shlomai","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1200\/JCO.2017.76.3524","article-title":"Diabetes after hormone therapy in breast cancer survivors: A case-cohort study","volume":"36","author":"Hamood","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/gut.42.6.792","article-title":"Use of somatostatin analogue ocreotide to localize and manage somatostatin-producing tumours","volume":"42","author":"Angeletti","year":"1998","journal-title":"Gut"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double blind, prospective, randomized study on the effect of Octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine mid gut tumors. A report from PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_311","first-page":"18","article-title":"Diabetic ketoacidosis following PEG-asparaginase therapy","volume":"2018","author":"Ahmad","year":"2018","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_312","first-page":"311","article-title":"Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia","volume":"63","author":"Komatsu","year":"2016","journal-title":"Endocrinol. J."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1677\/ERC-09-0221","article-title":"Hyperglycemia confers resistance to chemotherapy on breast cancer cells: The role of fatty acid synthase","volume":"17","author":"Zeng","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1158\/1078-0432.CCR-07-0244","article-title":"Hyperglycemia-induced thioredoxin-interacting protein expression in breast cancer-derived cells and regulates paclitaxel IC50","volume":"13","author":"Turturro","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1463-1318.2012.03097.x","article-title":"Secondary diabetes associated with 5-fluorouracil-based chemotherapy regimens in non-diabetic patients with colorectal cancer: Results from a single-centre cohort study","volume":"15","author":"Feng","year":"2013","journal-title":"Color. Dis."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ctrv.2015.02.007","article-title":"Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect","volume":"41","author":"Ariaans","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: An overview","volume":"122","author":"Viollet","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"ref_319","doi-asserted-by":"crossref","unstructured":"Franciosi, M., Lucisano, G., Lapice, E., Sreippoli, G.F., Pellegrini, F., and Nicolucci, A. (2013). Metformin therapy and risk of cancer in patients with type 2 diabetes: Systematic review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071583"},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canep.2012.12.009","article-title":"Association of metformin use with cancer incidence and mortality: A meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12935-021-02202-5","article-title":"Cancer and diabetes: The interlinking metabolic pathways and repurposing actions of antidiabetic drugs","volume":"21","author":"Olatude","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-015-3331-5","article-title":"The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes","volume":"150","author":"Vissers","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-12-0369","article-title":"Diabetes, metformin use, and colon cancer: A population-based cohort study in Taiwan","volume":"167","author":"Tseng","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.18632\/aging.101019","article-title":"Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus","volume":"8","author":"Tseng","year":"2016","journal-title":"Aging"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/thy.2019.0851","article-title":"Metformin reduces thyroid cancer growth in the metastatic niche bone by inhibiting osteoblastic RANKL productions","volume":"31","author":"Shin","year":"2021","journal-title":"Thyroid"},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1210\/jc.2012-3799","article-title":"Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer","volume":"98","author":"Costello","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1089\/thy.2017.0550","article-title":"Protective effect of metformin against thyroid cancer development: A population-based study in Korea","volume":"28","author":"Cho","year":"2018","journal-title":"Thyroid"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2174\/0929867324666170412145232","article-title":"Effect of metformin and statin use on survival in pancreatic cancer patients: A systemic literature review and meta-analysis","volume":"25","author":"Graber","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"e2749","DOI":"10.1097\/MD.0000000000002749","article-title":"Metformin is associated with slightly reduced risk of colorectal cancer and moderate survival benefits in diabetes mellitus: A meta-analysis","volume":"95","author":"He","year":"2016","journal-title":"Medicine"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4048\/jbc.2015.18.3.264","article-title":"Association between metformin therapy and breast cancer incidence and mortality: Evidence from a meta-analysis","volume":"18","author":"Yang","year":"2015","journal-title":"J. Breast Cancer"},{"key":"ref_331","doi-asserted-by":"crossref","unstructured":"Lee, T.Y., Martinez-Outschoorn, U.E., Schilder, R.J., Kim, C.H., Richard, S.D., Rosenblum, N.G., and Johnson, J.M. (2018). Metformin as a therapeutic target in endometrial cancer. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00341"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/s41598-018-38285-w","article-title":"The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis","volume":"9","author":"He","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s00125-012-2653-7","article-title":"Cancer outcome and all-cause mortality in adults allocated to metformin: Systematic review and collaborative meta-analysis of randomized clinical trials","volume":"55","author":"Stevens","year":"2012","journal-title":"Diabetologia"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"81","DOI":"10.20452\/pamw.1029","article-title":"Do we have enough data to confirm the link between antidiabetic drug use and cancer development?","volume":"121","author":"Drzewoski","year":"2011","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tem.2020.05.004","article-title":"Rethinking the relationship between insulin and cancer","volume":"31","author":"Vigneri","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40880-017-0184-9","article-title":"Metformin targets multiple signaling pathways in cancer","volume":"36","author":"Lei","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"ref_337","doi-asserted-by":"crossref","unstructured":"Garcia-Saenz, M., Lobaton-Ginsberg, M., and Ferreira-Hermosillo, A. (2022). Metformin in differentiated thyroid cancer: Molecular pathways and its clinical implications. Biomolecules, 12.","DOI":"10.3390\/biom12040574"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1007\/s13277-015-3315-4","article-title":"Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway","volume":"36","author":"Han","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1530\/JME-19-0083","article-title":"The role of an anti-diabetic drug metformin in the treatment of endocrine tumors","volume":"63","author":"Thakur","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0140-6736(09)61029-1","article-title":"Thiazolidinediones and clinical outcomes in type 2 diabetes","volume":"373","author":"Retnakaran","year":"2009","journal-title":"Lancet"},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/VHRM.S993","article-title":"Peroxisome proliferator-activated recepto-gamma agonists and diabetes: Current evidence and future perspectives","volume":"4","author":"Chiarelli","year":"2008","journal-title":"Vasc. Health Ris. Manag."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2004.03.012","article-title":"Peroxisome proliferator-associated receptor gamma in diabetes and metabolism","volume":"25","author":"Rangwala","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_343","first-page":"25","article-title":"Thiazolidinediones as anti-cancer agents","volume":"6","author":"Blanquicett","year":"2008","journal-title":"Cancer Ther."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/dc07-2308","article-title":"Rosiglitazone and risk of cancer: A meta-analysis of randomized clinical trials","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pds.1352","article-title":"Cancer risk in thiazolidinedione users compared to other anti-diabetic agents","volume":"16","author":"Karo","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"e2961","DOI":"10.1002\/dmrr.2961","article-title":"Thiazolidinedione therapy and breast cancer risk in diabetic women: A systematic review and meta-analysis","volume":"34","author":"Du","year":"2018","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective Pioglitazone Clinical Trial in Macrovasculature Events): A randomized controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"ref_348","doi-asserted-by":"crossref","unstructured":"Lv, S., Wang, W., Wang, H., Zhu, Y., and Lei, C. (2019). PPARgamma activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5426-6"},{"key":"ref_349","doi-asserted-by":"crossref","unstructured":"Lamichane, S., Dahal Lamichane, B., and Kwon, S.M. (2018). Pivotal roles of peroxisome proliferator-activated receptors (PPARs) and their signal cascade for cellular and whole-body energy homeostasis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19040949"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/0973-1482.208753","article-title":"The administration of peroxisome proliferator-activated receptors alpha\/gamma agonist TZD18 inhibits cell growth and induces apoptosis in human gastric cancer cell lines","volume":"15","author":"Ma","year":"2019","journal-title":"J. Cancer Res. Ther."},{"key":"ref_351","doi-asserted-by":"crossref","unstructured":"Mazzone, P.J., Rai, H., Beukemann, M., Xu, M., Jain, A., and Sasidhar, M. (2012). The effect of metformin and thiazolidinedione use on lung cancer in diabetes. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-410"},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00592-013-0504-8","article-title":"Thiazolidinediones and cancer: Results of a meta-analysis of randomized clinical trials","volume":"51","author":"Monami","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"10147","DOI":"10.1038\/srep10147","article-title":"Pharmacologic therapy of diabetes and overall cancer risk and mortality. A meta-analysis of 265 studies","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/07853890.2013.851865","article-title":"Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes","volume":"45","author":"Tseng","year":"2013","journal-title":"Ann. Med."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/JCMA.0000000000000389","article-title":"Combination of peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists induces sodium\/iodide symporter expression and inhibits cell growth of human thyroid cancer cells","volume":"83","author":"Chen","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3803\/EnM.2021.1155","article-title":"Lobeglitazone, a peroxisome proliferator-activated receptor-gamma agonist, inhibits papillary thyroid cancer cell migration and invasion by suppressing p38 MAPK signaling pathway","volume":"36","author":"Jin","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1002\/jcp.26225","article-title":"Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARgamma-independent pathway","volume":"233","author":"Tsubaki","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4161\/cc.8.2.7584","article-title":"Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPAR\u03b3-dependent and PPAR\u03b3-independent pathways","volume":"8","author":"Lyles","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1634\/theoncologist.2012-0302","article-title":"Cancer risk for patients using thiazolidinediones for type 2 diabetes: A meta-analysis","volume":"18","author":"Bosetti","year":"2013","journal-title":"Oncologist"},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1503\/cmaj.112102","article-title":"Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: A meta-analysis","volume":"184","author":"Colmers","year":"2012","journal-title":"Can. Med. Associat. J."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2015.7996","article-title":"Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes","volume":"314","author":"Lewis","year":"2015","journal-title":"JAMA"},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"State of the art paper Sulfonylureas and their use in clinical practice","volume":"4","author":"Sola","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"ref_363","first-page":"61","article-title":"Type 2 diabetes and oral antihyperglycemic drugs","volume":"15","author":"Avery","year":"2008","journal-title":"Curr. Med."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1158\/0008-5472.CAN-17-0687","article-title":"Diabetes treatments and risks of adverse breast cancer outcomes among early-stage breast cancer patients: A SEER-Medicare analysis","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/1753-0407.12435","article-title":"Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review","volume":"9","author":"Chen","year":"2017","journal-title":"J. Diabetes"},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.metabol.2013.01.014","article-title":"Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: A meta-analysis using primary data of published studies","volume":"62","author":"Thakkar","year":"2013","journal-title":"Metabolism"},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1634\/theoncologist.2013-0177","article-title":"Effects of sulfonylureas on tumor growth: A review of the literature","volume":"18","author":"Pasello","year":"2013","journal-title":"Oncologist"},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.diabres.2018.04.002","article-title":"Diabetes and cancer: Pathophysiological fundamentals of a \u201cdangerous affair\u201d","volume":"143","author":"Cignarelli","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1158\/1535-7163.MCT-18-1181","article-title":"Glibenclamide targets sulfonylurea receptor 1 to inhibit p70S6K activity and upregulate KLF4 expression to suppress non-small cell lung carcinoma","volume":"18","author":"Xu","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.bcp.2008.09.009","article-title":"Glibendamide exerts an anti-tumor activity through reactive oxygen species-c-jun (NH2)-terminal kinase pathway in human gastric cancer cell line MGC-803","volume":"76","author":"Qian","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/dom.13745","article-title":"Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials","volume":"21","author":"Dicembrini","year":"2019","journal-title":"Diabetes. Obes. Metab."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1007\/s00125-017-4434-9","article-title":"SGLT2 inhibitors and cancer: Why further evidence is required","volume":"60","author":"Shaikh","year":"2017","journal-title":"Diabetologia"},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s13300-015-0128-9","article-title":"Assessing bladder cancer risk in type 2 diabetes clinical trials: The dapaglioflozin drug development program as a \u201cCase Study\u201d","volume":"6","author":"Ptaszynska","year":"2015","journal-title":"Diabetes Ther."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40170-019-0203-1","article-title":"SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia","volume":"7","author":"Nasiri","year":"2019","journal-title":"Cancer Metab."},{"key":"ref_376","doi-asserted-by":"crossref","unstructured":"Jojima, T., Wakamatsu, S., Kase, M., Iijima, Y., Maejima, Y., Shimomura, K., Kogai, T., Tomaru, T., Usui, I., and Aso, Y. (2019). The SGLT2 inhibitor canagliflozin prevents carcinogenesis in a mouse model of diabetes and non-alcoholic steatohepatitis-related hepatocarcinogenesis: Association with SGLT2 expression in hepatocellular carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205237"},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ijc.31193","article-title":"Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer growth and angiogenic activity by inhibiting glucose uptake","volume":"142","author":"Kaji","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41419-019-1646-6","article-title":"Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced \u03b2-catenin activation","volume":"10","author":"Hung","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"E4111","DOI":"10.1073\/pnas.1511698112","article-title":"Functional expression of sodium-glucose transporters in cancer","volume":"112","author":"Scafoglio","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1007\/s00125-017-4430-0","article-title":"Bladder cancer in the EMPA-REG OUTCOME trial","volume":"60","author":"Kohler","year":"2017","journal-title":"Diabetologia"},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metab."},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"115119","DOI":"10.1016\/j.ejmech.2023.115119","article-title":"Synthetic alpha-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges","volume":"249","author":"Mauhtaq","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"2651790","DOI":"10.1155\/2022\/2651790","article-title":"The effects of 6 common antidiabetic drugs on anti-PD1 immune checkpoint inhibitor in tumor treatment","volume":"2022","author":"Zhan","year":"2022","journal-title":"J. Immunol. Res."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cllc.2011.10.002","article-title":"Antidiabetic drugs correlate with decreased risk of lung cancer: A population-based observation in Taiwan","volume":"13","author":"Lai","year":"2012","journal-title":"Clin. Lung Cancer"},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2337\/dc15-0563","article-title":"Use of an alpha-glucosidase inhibitor and the risk of colorectal cancer in patients with diabetes: A nationwide population-based cohort study","volume":"38","author":"Tseng","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12020-020-02291-8","article-title":"Effect of type 2 diabetes and antihyperglycemic drug therapy on signs of tumor invasion in papillary thyroid cancer","volume":"69","author":"Li","year":"2020","journal-title":"Endocrine"},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation","volume":"151","author":"Madsen","year":"2010","journal-title":"Endocrinology"},{"key":"ref_388","first-page":"E1","article-title":"GLP-1 receptor agonists and colorectal cancer risk in drug na\u00efve patients with type 2 diabetes, with and without overweight\/obesity","volume":"7","author":"Wang","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00125-011-2381-4","article-title":"Cancer occurrence in Danish diabetic patients: Duration and insulin effect","volume":"55","author":"Carstensen","year":"2012","journal-title":"Diabetologia"},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12672-012-0112-z","article-title":"Systemic review and meta-analysis of insulin therapy and risk of cancer","volume":"3","author":"Janghorbani","year":"2012","journal-title":"Hormon. Cancer"},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1200\/JCO.2017.73.4491","article-title":"Long-term use of long-acting analogs and breast cancer incidence in women with type 2 diabetes","volume":"35","author":"Wu","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1210\/en.2005-1012","article-title":"Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo","volume":"147","author":"Tran","year":"2006","journal-title":"Endocrinology"},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/dmrr.912","article-title":"Insulin analogues display IGF-1-like mitogenic and anti-apoptotic activities in culture cancer cells","volume":"25","author":"Weinstein","year":"2009","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1677\/ERC-08-0240","article-title":"Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines","volume":"16","author":"Shukla","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/dc15-1816","article-title":"Effect of long-acting insulin analogs on the risk of cancer: A systematic review of observational studies","volume":"39","author":"Wu","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_396","doi-asserted-by":"crossref","unstructured":"Sciacca, L., Le Moli, R., and Vigneri, R. (2012). Insulin analogs and cancer. Front. Endocrinol., 3.","DOI":"10.3389\/fendo.2012.00021"},{"key":"ref_397","doi-asserted-by":"crossref","unstructured":"ORIGIN Trial Investigators, Gerstein, H.C., Bosch, J., Dagenais, G.R., Diaz, R., Jung, H., Maggioni, A.P., Pogue, J., Probstfield, J., and Ramachandran, A. (2012). Basal insulin and cardiovascular and other outcomes in dysglycemia. N. Engl. J. Med., 2, 319\u2013328.","DOI":"10.1056\/NEJMoa1203858"},{"key":"ref_398","doi-asserted-by":"crossref","unstructured":"ORIGIN Trial Investigators (2016). Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE). Diabetes Care, 39, 709\u2013716.","DOI":"10.2337\/dc15-1676"},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/15748863113086660071","article-title":"CARING (Cancer Risk and Insulin analoGues): The association of diabetes mellitus and cancer risk with focus on possible determinants. A systematic review and meta-analysis","volume":"8","author":"Karlstad","year":"2013","journal-title":"Curr. Drug Saf."},{"key":"ref_400","doi-asserted-by":"crossref","unstructured":"Sommerfeld, M.R., Muller, G., Tschank, G., Seipke, G., Habermann, P., Kurrle, R., and Tennagels, N. (2010). In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009540"},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.2337\/dc14-0584","article-title":"Metformin does not affect cancer risk: A cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial","volume":"37","author":"Tsilidis","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_403","doi-asserted-by":"crossref","unstructured":"Padma, V.V. (2015). An overview of targeted cancer therapy. BioMedicine, 5.","DOI":"10.7603\/s40681-015-0019-4"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1530\/JME-18-0002","article-title":"Novel cancer therapies and their associations with diabetes","volume":"62","author":"Shariff","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"628582","DOI":"10.3389\/fendo.2021.628582","article-title":"Association of common genetic risk variants with gestational diabetes mellitus and their role in GDM prediction","volume":"12","author":"Popova","year":"2021","journal-title":"Front. Endocrinol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/13\/7476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:11:33Z","timestamp":1760109093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/13\/7476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":405,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ijms25137476"],"URL":"https:\/\/doi.org\/10.3390\/ijms25137476","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]}}}